[1] |
Xiao Z, Dai Z, Locasale JW. Metabolic landscape of the tumor microenvironment at single cell resolution[J]. Nat Commun, 2019,10(1): 3763. doi: 10.1038/s41467⁃019⁃11738⁃0.
|
[2] |
Zhu M, Liu X, Wang Y, et al. YAP via interacting with STAT3 regulates VEGF⁃induced angiogenesis in human retinal microvascular endothelial cells[J]. Exp Cell Res, 2018,373(1⁃2):155⁃163. doi: 10.1016/j.yexcr.2018.10.007.
|
[3] |
Ascierto PA, Grimaldi AM, Anderson AC, et al. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th⁃8th 2013[J]. J Transl Med, 2014,12:277. doi: 10.1186/s12967⁃014⁃0277⁃z.
|
[4] |
Zeng Q, Li S, Chepeha DB, et al. Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling[J]. Cancer Cell, 2005,8(1):13⁃23. doi: 10.1016/j.ccr.2005.06.004.
|
[5] |
Fischer GM, Vashisht Gopal YN, McQuade JL, et al. Metabolic strategies of melanoma cells: mechanisms, interactions with the tumor microenvironment, and therapeutic implications[J]. Pigment Cell Melanoma Res, 2018,31(1):11⁃30. doi: 10.1111/pcmr.12661.
|
[6] |
Ribatti D, Nico B, Crivellato E, et al. The history of the angiogenic switch concept[J]. Leukemia, 2007,21(1):44⁃52. doi: 10.1038/sj.leu.2404402.
|
[7] |
Gu J, Li G, Sun T, et al. Blockage of the STAT3 signaling pathway with a decoy oligonucleotide suppresses growth of human malignant glioma cells[J]. J Neurooncol, 2008,89(1):9⁃17. doi: 10.1007/s11060⁃008⁃9590⁃9.
|
[8] |
Johnson DE, O′Keefe RA, Grandis JR. Targeting the IL⁃6/JAK/STAT3 signalling axis in cancer[J]. Nat Rev Clin Oncol,2018,15(4):234⁃248. doi: 10.1038/nrclinonc.2018.8.
|
[9] |
Kumari N, Dwarakanath BS, Das A, et al. Role of interleukin⁃6 in cancer progression and therapeutic resistance[J]. Tumour Biol, 2016,37(9):11553⁃11572. doi: 10.1007/s13277⁃016⁃5098⁃7.
|
[10] |
Camporeale A, Poli V. IL⁃6, IL⁃17 and STAT3: a holy trinity in auto⁃immunity?[J]. Front Biosci (Landmark Ed), 2012,17:2306⁃2326. doi: 10.2741/4054.
|
[11] |
Yuan G, Yan S, Xue H, et al. JSI⁃124 suppresses invasion and angiogenesis of glioblastoma cells in vitro[J/OL]. PLoS One, 2015,10(3):e0118894[2019⁃10⁃16]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366361/. doi: 10.1371/journal.pone.0118894.
|
[12] |
Ishdorj G, Johnston JB, Gibson SB. Cucurbitacin⁃I (JSI⁃124) activates the JNK/c⁃Jun signaling pathway independent of apoptosis and cell cycle arrest in B leukemic cells[J]. BMC Cancer, 2011,11:268. doi: 10.1186/1471⁃2407⁃11⁃268.
|
[13] |
Molavi O, Mahmud A, Hamdy S, et al. Development of a poly(d,l⁃lactic⁃co⁃glycolic acid) nanoparticle formulation of STAT3 inhibitor JSI⁃124: implication for cancer immunotherapy[J]. Mol Pharm, 2010,7(2):364⁃374. doi: 10.1021/mp900145g.
|
[14] |
Sajadimajd S, Bahramsoltani R, Iranpanah A, et al. Advances on natural polyphenols as anticancer agents for skin cancer[J]. Pharmacol Res, 2020,151:104584. doi: 10.1016/j.phrs.2019.10 4584.
|